ESC 365 - GRK2 is a novel early marker of cardiotoxicity in response to doxorubicin

HFA Premium Access

GRK2 is a novel early marker of cardiotoxicity in response to doxorubicin

Session: Poster Session 3 - Basic Science - Autoimmune/Chronic Inflammatory Disorders and Heart Disease

Topic: Autoimmune/Chronic Inflammatory Disorders and Heart Disease

Speaker: Doctor M. De Rosa (Chieti, IT)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Doctor Matteo De Rosa

G. d Annunzio University, Chieti (Italy)

0 follower

Access the full session

Poster Session 3 - Basic Science - Autoimmune/Chronic Inflammatory Disorders and Heart Disease

Speakers: Doctor M. De Rosa

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources